萊姆病檢驗(體外診斷)-全球市場分析及預測模式(COVID-19對市場造成的影響)

本報告詳細探討2020年及以後的COVID-19對萊姆病測試市場的影響。萊姆病是一種由伯氏疏螺旋體（Borrelia burgdorferi）細菌引起的炎性疾病，並通過蜱(Tick，又稱為壁蝨)叮咬人體後，傳播給人。

據世界衛生組織稱，萊姆病在亞洲，西北，中歐和東歐以及美國的森林地區更為突出。農村地區的遊客更容易感染伯氏疏螺旋體。萊姆病的診斷分為兩階段，其中必須通過西方墨點法確認萊姆病。報告的病例表明僅懷疑患有萊姆病的患者，而確診病例是在兩種診斷測試中均呈陽性的患者。萊姆病測試分為萊姆病酶免疫測定測試，萊姆病Western Blot測試和萊姆病其他測試。

本報告提供萊姆病檢驗市場相關調查，提供市場概要，以及2015∼2030年的市場預測，各市場區隔，各國的趨勢等資訊。

• 主要的產業趨勢洞察
• 2015年∼2030年各分類市場預測
• 手術數量，台數，平均銷售價格，各分類市場價值相關詳細資料

全球地區，各國趨勢

• 各國分析
• SWOT分析
• 競爭趨勢

健康護理系統概要

• 醫療保健制度的各國概要
• 各國給付方針
• 國家固有的醫療技術相關法規趨勢

網羅的企業:PerkinElmer Inc，bioMerieux SA，Meridian Bioscience Inc，Bio-Rad Laboratories Inc，Thermo Fisher Scientific Inc，其他

觀察對象國家:美國，英國，德國，法國，義大利，西班牙，巴西，中國，印度，俄羅斯，日本，澳洲，加拿大，墨西哥，韓國，丹麥，愛爾蘭，荷蘭，紐西蘭，南非，瑞典，瑞士，奧地利，比利時，芬蘭，以色列，挪威，波蘭葡萄牙，台灣，捷克，希臘，匈牙利，土耳其，埃及，沙烏地阿拉伯，阿拉伯聯合大公國，阿根廷，智利

Lyme Disease Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.

The model discusses in detail the impact of COVID-19 on Lyme disease Tests market for the year 2020 and beyond. Lyme disease is an inflammatory disease caused by the bacterium Borrelia burgdorferi and is transmitted through the bite of infected ticks of the genus Ixodes.

According to the WHO, Lyme disease is more prominent in forested areas of Asia, north-western, central and eastern Europe, and the USA. Visitors to rural areas are more prone to infection with B. burgdorferi. Diagnosis of Lyme disease occurs as a two-tiered test where confirmation of Lyme disease by Western Blot is essential. Reported cases indicate only patients suspected of having Lyme disease, whereas confirmed cases are the patients who tested positive in both diagnostic tests. Lyme Disease Tests is segmented into Lyme Disease Enzyme Immunoassay Test, Lyme Disease Western Blot Test, and Lyme Disease Other Tests.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Lyme Disease Tests and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Lyme Disease Tests market revenue by segment and market outlooks from 2015-2030.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Lyme Disease Tests market.
• Competitive dynamics insights and trends provided for Lyme Disease Tests market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - PerkinElmer Inc, bioMerieux SA, Meridian Bioscience Inc, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, and Others

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope

Who should buy this report?

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Lyme Disease Tests market place to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Lyme Disease Tests market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Lyme Disease Tests market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Lyme Disease Tests market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Lyme Disease Tests market from 2015-2030.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.